Related references
Note: Only part of the references are listed.Can Neuropeptide S Be an Indicator for Assessing Anxiety in Psychiatric Disorders?
Agnieszka Markiewicz-Gospodarek et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Role of the Neuropeptide S System in Emotionality, Stress Responsiveness and Addiction-Like Behaviours in Rodents: Relevance to Stress-Related Disorders
Ann-Marie Tobinski et al.
PHARMACEUTICALS (2021)
Spexin-expressing neurons in the magnocellular nuclei of the human hypothalamus
Artur Palasz et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2021)
Conceptual disorganization and redistribution of resting-state cortical hubs in untreated first-episode psychosis: A 7T study
Avyarthana Dey et al.
NPJ SCHIZOPHRENIA (2021)
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
Caitlin E. Murphy et al.
TRANSLATIONAL PSYCHIATRY (2021)
Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity
Valentina Albanese et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Reinforcement of Self-Regulated Brain Activity in Schizophrenia Patients Undergoing Rehabilitation
Renata Markiewicz et al.
Biomed Research International (2021)
The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions
Luca Botticelli et al.
PHARMACEUTICALS (2021)
Roles of Neuropeptide S in Anesthesia, Analgesia, and Sleep
Tetsuya Kushikata et al.
PHARMACEUTICALS (2021)
Improving Clinical, Cognitive, and Psychosocial Dysfunctions in Patients with Schizophrenia: A Neurofeedback Randomized Control Trial
Renata Markiewicz et al.
NEURAL PLASTICITY (2021)
Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia
Keane Lim et al.
ASIAN JOURNAL OF PSYCHIATRY (2021)
Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
Victor A. D. Holanda et al.
PHARMACEUTICALS (2021)
Corticosterone Treatment and Incubation Time After Contextual Fear Conditioning Synergistically Induce Fear Memory Generalization in Neuropeptide S Receptor-Deficient Mice
Malgorzata H. Kolodziejczyk et al.
FRONTIERS IN NEUROSCIENCE (2020)
Amygdala, neuropeptides, and chronic pain-related affective behaviors
Volker Neugebauer et al.
NEUROPHARMACOLOGY (2020)
Cognitive and Social Rehabilitation in Schizophrenia-From Neurophysiology to Neuromodulation. Pilot Study
Renata Markiewicz et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation
Ashley L. Comer et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Neuropeptide S receptor gene Asn107 polymorphism in obese male individuals in Pakistan
Aftab Ahmad et al.
PLOS ONE (2020)
Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders
Chris Greene et al.
TRANSLATIONAL PSYCHIATRY (2020)
Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies
Jesper Futtrup et al.
BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2020)
Neuropeptide S Ameliorates Cognitive Impairment of APP/PSI Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition
Peng Zhao et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap
Sohei Kimoto et al.
NEUROBIOLOGY OF DISEASE (2019)
Plasma Neuropeptide-S Levels in Populations Diagnosed with Generalized Anxiety Disorder: A Controlled Study
Hayriye Baykan et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2019)
Can brain-derived neurotrophic factor (BDNF) be an indicator of effective rehabilitation interventions in schizophrenia?
Renata Markiewicz et al.
PSYCHIATRIA POLSKA (2018)
Relationship between panic disorder and plasma neuropeptide-S level
Hayriye Baykan et al.
ARCHIVES OF CLINICAL PSYCHIATRY (2018)
Neuropeptide systems and new treatments for nicotine addiction
Adriaan W. Bruijnzeel
PSYCHOPHARMACOLOGY (2017)
Adolescent Stress as a Driving Factor for Schizophrenia Development-A Basic Science Perspective
Felipe V. Gomes et al.
SCHIZOPHRENIA BULLETIN (2017)
Long-term treatment with haloperidol affects neuropeptide S and NPSR mRNA levels in the rat brain
Artur Palasz et al.
ACTA NEUROPSYCHIATRICA (2016)
Long-term treatment with haloperidol affects neuropeptide S and NPSR mRNA levels in the rat brain
Artur Palasz et al.
ACTA NEUROPSYCHIATRICA (2016)
Intra-amygdala microinfusion of neuropeptide S attenuates neuropathic pain and suppresses the response of spinal microglia and astrocytes after spinal nerve ligation in rats
Fengrui Yang et al.
PEPTIDES (2016)
Neuropeptide S inhibits gastrointestinal motility and increases mucosal permeability through nitric oxide
Wan Salman Wan Saudi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain
Artur Palasz et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons
Csaba Adori et al.
FRONTIERS IN NEUROANATOMY (2015)
Neuropeptide S receptor gene variant and environment: contribution to alcohol use disorders and alcohol consumption
Kariina Laas et al.
ADDICTION BIOLOGY (2015)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Golam M. Khandaker et al.
LANCET PSYCHIATRY (2015)
Cognitive Interventions Targeting Brain Plasticity in the Prodromal and Early Phases of Schizophrenia
Melissa Fisher et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 9 (2013)
The role of the neuropeptide S system in addiction: Focus on its interaction with the CRF and hypocretin/orexin neurotransmission
Nazzareno Cannella et al.
PROGRESS IN NEUROBIOLOGY (2013)
The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response
Leonhard Lennertz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression
Gregers Wegener et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing Neurons
Irina A. Ionescu et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Intraventricular administration of neuropeptide S has reward-like effects
Junran Cao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Anatomical Characterization of the Neuropeptide S System in the Mouse Brain by In Situ Hybridization and Immunohistochemistry
Stewart D. Clark et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2011)
Efficacy of iloperidone in schizophrenia: A PANSS five-factor analysis
Leslie Citrome et al.
SCHIZOPHRENIA RESEARCH (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMC MEDICINE (2010)
Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801
Naoe Okamura et al.
NEUROPHARMACOLOGY (2010)
Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1
Hongyan Zhu et al.
PSYCHONEUROENDOCRINOLOGY (2010)
Biological and genetic interaction between Tenascin C and Neuropeptide S receptor 1 in allergic diseases
Christina Orsmark-Pietras et al.
HUMAN MOLECULAR GENETICS (2008)
Nicotine treatment regulates neuropeptide S system expression in the rat brain
Ricardo Lage et al.
NEUROTOXICOLOGY (2007)
Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder
Naoe Okamura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects
YL Xu et al.
NEURON (2004)
Share Paper
